Free Trial

Benjamin Haynor Analyst Performance

Analyst at Lake Street Capital

Benjamin Haynor is a stock analyst at Lake Street Capital in the medical sector, covering 3 publicly traded companies. Over the past year, Benjamin Haynor has issued 4 stock ratings, including and buy recommendations. While full access to Benjamin Haynor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Benjamin Haynor's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
4 Last 0 Years
Buy Recommendations
100.00% 3 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%3 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
66.7% of companies on NYSE
2 companies
NASDAQ
33.3% of companies on NASDAQ
1 company

Benjamin Haynor, an analyst at Lake Street Capital, currently covers 3 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
3 companies
100.0%

Benjamin Haynor of Lake Street Capital specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
SURGICAL & MEDICAL INSTRUMENTS
1 company
33.3%
ELECTROMEDICAL EQUIPMENT
1 company
33.3%
MED - DRUGS
1 company
33.3%

Benjamin Haynor's Ratings History at Lake Street Capital

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
9/22/2025Initiated Coverage$10.14$15.00Buy
Electromed, Inc. stock logo
ELMD
Electromed
8/27/2025Set Price Target$24.66$36.00
Electromed, Inc. stock logo
ELMD
Electromed
8/27/2025Initiated Coverage$24.33$36.00Buy
Profound Medical stock logo
PROF
Profound Medical
4/23/2025Lower Price Target$4.75$11.00Buy